おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
HLS Therapeutics
company
About
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.
- 101 - 250
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $91.10M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity. HLS ensures the availability of treatments critical to patients and their caregivers with the brand names they trust.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$91.10M
HLS Therapeutics has raised a total of
$91.10M
in funding over 2 rounds. Their latest funding was raised on
Oct 3, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 3, 2022 | Post-IPO Debt | $91.10M | 1 |
JP Morgan Chase
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
HLS Therapeutics is funded by 1 investors.
JP Morgan Chase
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
JP Morgan Chase
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
